Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 10 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
Switch redundancy in systems with dual-star backplanes
Global codebook for coordinated multi-point processing
Electron beam manipulation system and method in X-ray sources
Porous objects having immobilized encapsulated biomolecules
High conductive water-based silver ink
NMR, instrumentation, and flow meter/controller continuously detecting MR signals, from continuously flowing sample material
  Randomly Featured Patents
Base material for revascularization
Anode material for lithium secondary battery, process for production thereof, and lithium secondary battery
Finger mounted specialty grasper
Transparent shoe storage box
Magnetoresistive device with enhanced pinned layer
Hierarchical data collection network supporting packetized voice communications among wireless terminals and telephones
Dual beam system
Truss supported/tool supporting system
Recoil reducer